Pulmonx Corporation
NASDAQ: LUNG0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Glendon E. French
- Employees
- 291
- Headquarters
- Redwood City, United States
- IPO year
- 2020
- Market cap
- $58.7M
- Website
- https://pulmonx.com
Loading LUNG…
Loading profile data…Frequently asked questions about LUNG
What does Pulmonx Corporation (LUNG) do?
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Comp...
Where does LUNG trade?
Pulmonx Corporation (LUNG) trades on the NASDAQ Global Select.
What sector is LUNG in?
Pulmonx Corporation (LUNG) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Pulmonx Corporation?
Glendon E. French is the chief executive officer of Pulmonx Corporation (LUNG).
Where is Pulmonx Corporation headquartered?
Pulmonx Corporation is headquartered in United States.
Does LUNG pay a dividend?
Pulmonx Corporation (LUNG) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LUNG go public?
Pulmonx Corporation (LUNG) completed its initial public offering in 2020.